Literature DB >> 22698521

Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2.

Natalija Novak1, Nihal Mete, Caroline Bussmann, Laura Maintz, Thomas Bieber, Mübeccel Akdis, Judith Zumkehr, Marek Jutel, Cezmi Akdis.   

Abstract

BACKGROUND: Early desensitization of FcεRI-bearing mast cells and basophils has been demonstrated in allergen-specific immunotherapy and drug desensitization. However, its mechanisms have not been elucidated in detail. Histamine is one of the main mediators released on FcεRI triggering of basophils and mast cells, and it exerts its functions through histamine receptors (HRs).
OBJECTIVES: We sought to investigate HR expression on basophils of patients undergoing venom immunotherapy (VIT) and its effect on allergen, IgE, and FcεRI cross-linking-mediated basophil function and mediator release.
METHODS: Basophils were purified from the peripheral blood of patients undergoing VIT and control subjects and were studied functionally by using real-time PCR, flow cytometry and ELISA assays.
RESULTS: Rapid upregulation of H2R within the first 6 hours of the build-up phase of VIT was observed. H2R strongly suppressed FcεRI-induced activation and mediator release of basophils, including histamine and sulfidoleukotrienes, as well as cytokine production in vitro.
CONCLUSION: Immunosilencing of FcεRI-activated basophils by means of selective suppression mediated by H2R might be highly relevant for the very early induction of allergen tolerance and the so-called desensitization effect of VIT.
Copyright © 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22698521     DOI: 10.1016/j.jaci.2012.04.039

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  34 in total

Review 1.  Preventing progression of allergic rhinitis to asthma.

Authors:  Jaymin B Morjaria; Massimo Caruso; Emma Rosalia; Cristina Russo; Riccardo Polosa
Journal:  Curr Allergy Asthma Rep       Date:  2014-02       Impact factor: 4.806

Review 2.  The use of biologics for immune modulation in allergic disease.

Authors:  Willem van de Veen; Mübeccel Akdis
Journal:  J Clin Invest       Date:  2019-03-18       Impact factor: 14.808

Review 3.  Venom immunotherapy: an updated review.

Authors:  Darío Antolín-Amérigo; Carmen Moreno Aguilar; Arantza Vega; Melchor Alvarez-Mon
Journal:  Curr Allergy Asthma Rep       Date:  2014-07       Impact factor: 4.806

Review 4.  Pros and Cons of Clinical Basophil Testing (BAT).

Authors:  Hans Jürgen Hoffmann; Edward F Knol; Martha Ferrer; Lina Mayorga; Vito Sabato; Alexandra F Santos; Bernadette Eberlein; Anna Nopp; Donald MacGlashan
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

Review 5.  The role of basophils as innate immune regulatory cells in allergy and immunotherapy.

Authors:  Salvatore Chirumbolo; Geir Bjørklund; Andrea Sboarina; Antonio Vella
Journal:  Hum Vaccin Immunother       Date:  2018-01-18       Impact factor: 3.452

Review 6.  Is clinical tolerance possible after allergen immunotherapy?

Authors:  Timothy P Moran; A Wesley Burks
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

Review 7.  Impact of allergen immunotherapy in allergic asthma.

Authors:  Wenming Zhang; Chunrong Lin; Vanitha Sampath; Kari Nadeau
Journal:  Immunotherapy       Date:  2018-03-23       Impact factor: 4.196

Review 8.  Modified Allergens for Immunotherapy.

Authors:  Pattraporn Satitsuksanoa; Anna Głobińska; Kirstin Jansen; Willem van de Veen; Mübeccel Akdis
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-16       Impact factor: 4.806

Review 9.  Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β.

Authors:  O Palomares; M Martín-Fontecha; R Lauener; C Traidl-Hoffmann; O Cavkaytar; M Akdis; C A Akdis
Journal:  Genes Immun       Date:  2014-07-24       Impact factor: 2.676

Review 10.  Histamine pharmacology: from Sir Henry Dale to the 21st century.

Authors:  Ekaterini Tiligada; Madeleine Ennis
Journal:  Br J Pharmacol       Date:  2018-12-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.